StockData

Caribou Biosciences vs TScan Therapeutics

CRBU and TCRX side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How CRBU and TCRX compare

Caribou Biosciences is the larger company, worth 3.8 times as much as TScan Therapeutics ($37.8M against $9.8M).

Caribou Biosciences grew revenue faster over the last twelve months (10.0% versus 2.2% for TScan Therapeutics).

Caribou Biosciences keeps more of each dollar of sales as profit, with a net margin of −1030% compared with −1655% at TScan Therapeutics.

Caribou Biosciences scores higher on the StockData Score (9 against 4 for TScan Therapeutics), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricCRBUTCRX
Size and price
Market cap$37.8M$9.8M
Share price$0.353$0.145
Change, 1 year−82.2%−87.2%
Change, 5 years−98.0%−98.3%
Beta (5Y)1.362.20
Employees97142
StockData Score
Total score9 (better)4
Valuation score33
Growth score1 (better)0
Performance score00
Health score5 (better)1
Dividend score00
Valuation
P/S3.8×1.4× (better)
P/B0.4×0.1× (better)
FCF yield−253% (better)−1204%
Fair value$1.29$1.36
Margin of safety72.6%89.3% (better)
Growth
Revenue growth (TTM)10.0% (better)2.2%
Revenue growth, 5Y average−2.0%56.9% (better)
Profitability
Operating margin−1091% (better)−1695%
Net margin−1030% (better)−1655%
FCF margin−954% (better)−1666%
Return on equity−78.3% (better)−95.8%
Financial health
Debt / equity0.000.47 (better)
Interest coverage–−43.2×
Current ratio6.49 (better)3.37
Altman Z-score−7.46−6.31 (better)
Piotroski F-score22
Dividends and buybacks
Buyback yield−64.0%–
Shareholder yield−64.0%0.00% (better)
Ownership
Held by institutions45.5%53.5%
Held by insiders5.7%32.8%
Insider net buying, 12 months−$47.5K$146K (better)
Short interest, % of float14.7%4.4%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.